• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Fresenius Kabi

    < Previous 1 2 Next >
    CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code and Pass-Through Payment Status for Tyenne® (tocilizumab-aazg)
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Inducts 12 into National Blood Donation Hall of Fame
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi and Formycon Receive U.S. FDA Approval for Biosimilar Otulfi™* (ustekinumab-aauz)
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi and AABB Announce Start of 19th Annual Blood Collectors Week September 1-7, 2024
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Expands Women’s Health Portfolio with New Generic Option for Reproductive Health
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Receives 2024 Trailblazer Award From Premier Inc. for Supply Chain Innovation
    From Fresenius Kabi
    Via Business Wire
    Arunesh Verma Joins Fresenius Kabi USA as President
    From Fresenius Kabi
    Via Business Wire
    Fresenius Continues its Biopharma Momentum with Launch of Subcutaneous Formulation of Tyenne® (tocilizumab-aazg) in the United States
    From Fresenius Kabi
    Via Business Wire
    Angels for Change 2024 Drug Shortage Guardian Award Presented to Fresenius Kabi USA
    From Fresenius Kabi
    Via Business Wire
    Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®, its Third Approved Biosimilar in the U.S.
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Further Expands Oncology Portfolio with Launch of Cyclophosphamide for Injection, USP
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Launches Posaconazole Injection for Prevention or Treatment of Fungal Infections
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi and Mayo Clinic Enter into Multiyear Supply and Service Agreement for the Ivenix® Infusion System
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Celebrates 25th Anniversary of National Blood Donation Hall of Fame by Honoring 2023 Heroes
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Introduces Smart Labels for Diprivan® with Embedded Fully Interoperable +RFID Technology
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Named 2023 Supplier Partner of the Year by Vizient
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Selected for Second Consecutive Year to Exhibit the Ivenix Infusion System at Vizient Innovative Technology Exchange
    From Fresenius Kabi
    Via Business Wire
    Virginia Oncology Associates Chooses the Ivenix Infusion System from Fresenius Kabi
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi and Lupagen Enter into Strategic Development and Supply Agreement to Bring Cell and Gene Therapies to the Bedside
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Launches Plerixafor Injection
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Further Expands Radiology Portfolio with Launch of Gadobutrol Injection
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Introduces New Presentation for Fentanyl Citrate Injection, USP in Simplist® Ready-to-Administer Prefilled Syringes
    From Fresenius Kabi
    Via Business Wire
    Expanding Access to Women’s Health Fresenius Kabi Launches Generic Fertility Treatment
    From Fresenius Kabi
    Via Business Wire
    IDACIO® (adalimumab-aacf) Now Available in the United States
    From Fresenius Kabi
    Via Business Wire
    Metrodora Institute, a Leader in Treating Complex Conditions, Chooses the Ivenix Infusion System from Fresenius Kabi
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Broadens Radiology Portfolio with its First-to-Market Authorized Generic, Sincalide for Injection
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Launches Vasopressin Injection, USP Expanding U.S. Critical Care Portfolio
    From Fresenius Kabi
    Via Business Wire
    Supporting Patient Safety: Fresenius Kabi Expands Ready-to-Administer Portfolio with Diazepam Injection, USP in Simplist® Prefilled Syringe
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Launches RFID-Enabled Rocuronium Bromide Injection, its First Product Compatible with Bluesight's KitCheck System
    From Fresenius Kabi
    Via Business Wire
    Fresenius Kabi Awarded Technology Breakthrough Agreement with Premier, Inc. for the Ivenix Infusion System
    From Fresenius Kabi
    Via Business Wire
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.